ADVERTISEMENT
ADVERTISEMENT

Norway bails out biotech

The Norwegian government hopes to stop its country's biotech from going out of business with a $418 million boost. The money is included in a new stimulus package released by the government Monday (Jan 26). "This is the most active political move in Europe regarding support to the biotech industry," Bjarte Reve, chief executive of the Oslo Cancer Cluster, which represents 25 Norwegian biotech groups told linkurl:Financial Times.;http://www.ft.com/cms/s/0/522b1038-ebb5-11dd-8838-0000779fd2ac.htm

Andrea Gawrylewski
The Norwegian government hopes to stop its country's biotech from going out of business with a $418 million boost. The money is included in a new stimulus package released by the government Monday (Jan 26). "This is the most active political move in Europe regarding support to the biotech industry," Bjarte Reve, chief executive of the Oslo Cancer Cluster, which represents 25 Norwegian biotech groups told linkurl:Financial Times.;http://www.ft.com/cms/s/0/522b1038-ebb5-11dd-8838-0000779fd2ac.html?nclick_check=1 Many European biotechs have been in financial freefall since last year's abysmal economic climate set in: Iceland's stock exchange was shut down in September, with prominent genetics company deCODE losing its listing on the NASDAQ biotechnology trading index, and UK biotechs clamored for a government bailout last month totaling nearly $1 billion. To put the stimulus in action, a state developmental agency called Innovation Norway is upping its loan amounts to biotech companies by $63 million a year, and a...



Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
ADVERTISEMENT